Bladder tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Adult male and female patients between the ages of 18 and 75. 2)Patients who are clinically diagnosed to require cystoscopy, including but not limited to bladder diverticulum, bladder stones, bladder tumors and other diseases diagnosed or treated. 3)Patients were able to understand the content of the study and voluntarily signed the informed consent form. 4)Patients are in good physical condition, without serious cardiac, hepatic or renal dysfunction, and without abnormal coagulation function. 5)Patients have not received cystoscopy in the past three months.
Exclusion criteria
Exclusion criteria: 1)Pregnant or nursing women. 2)Patients with known hypersensitivity to materials or medications used in cystoscopy. 3)Patients with uncontrolled urinary tract infections or other acute urinary tract disorders. 4)Patients with a history of severe mental illness or cognitive dysfunction that prevents them from cooperating in the completion of the study. 5)Patients with contraindications to cystoscopy, such as severe urethral stricture and bladder neck obstruction. 6)Patients who may not be expected to complete all follow-up visits during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White blood cells;Neutrophils;Lymphocytes;systemic immune-inflammatory index;neutrophil-lymphocyte ratio;platelet-lymphocyte ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Quality of Life Questionnaire;Postoperative Function Evaluation;Postoperative Life Satisfaction Scale;Postoperative Pain Assessment Scale; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University